Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Pfizer Inc. (NYSE:PFE) Shares Purchased by Transcend Capital Advisors LLC | news.google.com • |
3 Dividend Stocks to Buy and Hold for the Next Decade | fool.com • |
7 Dividend Stocks to Buy Now for Steady Returns in Any Market | investorplace.com • |
Pfizer (NYSE:PFE) Notches Up on New FDA Approval | news.google.com • |
Pfizer (NYSE:PFE) Hits New 52-Week Low at $25.20 | news.google.com • |
Pfizer Stock: Pharma Giant Takes On Hemgenix At $3.5 Million A Dose | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-01 | 2024-03 | 0.56 | N/A | N/A | N/A |
2024-01-30 | 2023-12 | -0.19 | 0.1 | 0.29 | 152.63% |
2023-10-31 | 2023-09 | -0.32 | -0.17 | 0.15 | 46.88% |
2023-08-01 | 2023-06 | 0.56 | 0.67 | 0.11 | 19.64% |
2023-05-02 | 2023-03 | 1 | 1.23 | 0.23 | 23.00% |
2023-01-31 | 2022-12 | 1.03 | 1.14 | 0.11 | 10.68% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-16 | Wells Fargo | Upgrade | Equal-Weight | Equal-Weight |
2023-10-16 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-10-16 | Truist Securities | Upgrade | Buy | Buy |
2023-10-15 | Jefferies | Upgrade | Hold | Buy |
2023-10-15 | Wells Fargo | Upgrade | Equal-Weight | Equal-Weight |
2023-10-15 | JP Morgan | Upgrade | Neutral | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-02-27 | BOSHOFF CHRISTOFFEL | Officer | 156.63K | Stock Award(Grant) |
2024-02-22 | BOURLA ALBERT | Chief Executive Officer | 332.49K | Conversion of Exercise of derivative security |
2024-02-26 | DAMICO JENNIFER B. | Officer | 13.50K | Stock Award(Grant) |
2024-02-26 | DE GERMAY ALEXANDRE | Officer | 74.38K | Stock Award(Grant) |
2023-12-14 | GOTTLIEB SCOTT | Director | 9.00K | Purchase |
2024-02-22 | JOHNSON RADY A | Officer | 103.45K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 508.09M | 18.64B | 9.00% |
2023-06-29 | Blackrock Inc. | 445.15M | 16.33B | 7.88% |
2023-06-29 | State Street Corporation | 287.20M | 10.53B | 5.09% |
2023-06-29 | Wellington Management Group, LLP | 233.11M | 8.55B | 4.13% |
2023-06-29 | Capital World Investors | 199.01M | 7.30B | 3.52% |
2023-06-29 | Geode Capital Management, LLC | 112.87M | 4.14B | 2.00% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 176.05M | 6.46B | 3.12% |
2023-06-29 | Vanguard 500 Index Fund | 134.41M | 4.93B | 2.38% |
2023-05-30 | Fidelity 500 Index Fund | 62.81M | 2.39B | 1.11% |
2023-08-30 | SPDR S&P 500 ETF Trust | 62.20M | 2.20B | 1.10% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 58.87M | 2.12B | 1.04% |
2023-08-30 | iShares Core S&P 500 ETF | 52.80M | 1.87B | 0.94% |
Dividend | Date |
---|---|
0.42 | 2024-05-09 |
0.42 | 2024-01-26 |
0.42 | 2024-01-25 |
0.41 | 2023-11-10 |
0.41 | 2023-11-09 |
0.41 | 2023-07-27 |
Split | Date |
---|---|
1054 : 1000 | 2020-11-17 |
3 : 1 | 1999-07-01 |
2 : 1 | 1997-07-01 |
2 : 1 | 1995-07-03 |
2 : 1 | 1991-04-01 |
2 : 1 | 1983-07-01 |
-
-
Pfe chief business officer on CNBC talking about production
-
38.73 close
-
Where’s the momentum? Shocked this isn’t flying with all the news coverage
-
I have 209 shares and pre market $38.59
-
The stock will see a pop will hit $40 today
-
-
Pfe is sitting on a golden egg,fast track approval,starting mfg two billion investment someone knows some serious news
-
How is it possible that pfe is being traded on Saturday
-
How is it possible that pfe is being traded on Saturday
-
CEO interview for vaccine by October
-
CEO just set bar to have PFE to have COVID-19 vaccine by fall
-
Today 5am: BERLIN—The German biotech firm that has partnered with Pfizer Inc. to develop a coronavirus vaccine is confident it will be ready to seek regulatory approval by the end of the year, according to its chief executive.
Several hundred million doses could be produced even before approval, and over 1 billion by the end of 2021.
-
We will see a steady nice climb !
-
We are in a nice strong and steady climb!
-
Pfizer Reports Encouarging Data From Coronavirus Program
July 2, 2020, 11:05 AM EDT
Pfizer Inc. PFE and its Germany-based biotech partner BioNTech SE BNTX announced encouraging preliminiary results from its early-stage coronavirus program. Their nucleoside-modified messenger RNA (modRNA) vaccine candidate, BNT162b1, generated signnifcantly higher receptor binding domain ("RBD") IgG antibodies and SARS-CoV-2 neutralizing antibodies compared to sera of convalescent patients who have recovered from COVID-19. -
Patience....
-
7 Dividend Stocks to Buy Now for Steady Returns in Any Market
investorplace.com • -
Pfizer (NYSE:PFE) Notches Up on New FDA Approval
news.google.com • -
Pfizer (NYSE:PFE) Hits New 52-Week Low at $25.20
news.google.com • -
Pfizer Stock: Pharma Giant Takes On Hemgenix At $3.5 Million A Dose
news.google.com • -
What Factors Will Drive Pfizer's Q1 Performance?
forbes.com • -
What Factors Will Drive Pfizer's Q1 Performance?
news.google.com • -
Pfizer (NYSE:PFE) Notches Up on New FDA Approval- TipRanks
news.google.com • -
June 7th Options Now Available For Pfizer (PFE)
news.google.com • -
What's Going On With Pfizer Stock On Thursday?- Benzinga
news.google.com • -
Bristol Myers posts quarterly loss, revenue rises 5%
news.google.com • -
Pfizer Declares Second-Quarter 2024 Dividend
news.google.com • -
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
news.google.com •